[1]Alp S, Gulmez D, Ayaz C, et al. Fungaemia due to rare yeasts in a tertiary care university centre within 18 years[J]. Mycoses,2020,63:488-493. [2]刘小平,樊尚荣,朱家琪,等. 从外阴分泌物中分离出一株深红酵母菌[J]. 四川生理科学杂志,2007,29:137-138. [3]Louria DB, Greenberg SM, Molander DW. Fungemia caused by certain nonpathogenic strains of the family Cryptococca-ceae. Report of two cases due to Rhodotorula and Torulopsis glabrata[J]. N Engl J Med,1960,263:1281-1284. [4]Elias A, Bodey GP, Hagop K, et al. New spectrum of fungal infections in patients with cancer[J]. Rev Infect Dis,1989,11:369-378. [5]Tuon FF, Costa SF. Rhodotorula infection. a systematic review of 128 cases from literature[J]. Rev Iberoame Micol,2008,25:135-140. [6]Falces-Romero I, Cendejas-Bueno E, MP Romero-Gómez, et al. Isolation of Rhodotorula mucilaginosa from blood cultures in a tertiary care hospital[J]. Mycoses, 2018,61:35-39. [7]Arendrup MC, Boekhout T, Akova M, et al. ESCMID/ECMM joint clinical guideline for the diagnosis and management of rare invasive yeast infections[J]. Clin Microbiol Infect, 2014, 20:76-98. [8]Mori T, Nakamura Y, Kato J, et al. Fungemia due to Rhodotorula mucilaginosa after allogeneic hematopoietic stem cell transplantation[J]. Transpl Infect Dis, 2012, 14:91-94. [9]Espinel-Ingroff A. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens[J]. J Clin Microbiol,1998,36:198-202. [10]Borba T, Spader, Mauricio, et al. In vitro interactions of amphotericin B combined with non-antifungal agents against Rhodotorula mucilaginosa strains[J]. Mycopathologia,2019,184:35-43. |